Related Experiment Video
Updated: Feb 11, 2026

Isolation and Activation of Murine Lymphocytes
Published on: October 30, 2016
Signaling lymphocytic activation molecules Slam and cancers: friends or foes?
Gregory Fouquet1, Ingrid Marcq1, Véronique Debuysscher1
1INSERM 1247-GRAP, Centre Universitaire de Recherche en Santé CURS, Université de Picardie Jules Verne, CHU Sud, Amiens, France.
Abstract:
Signaling Lymphocytic Activation Molecules (SLAM) family receptors are initially described in immune cells. These receptors recruit both activating and inhibitory SH2 domain containing proteins through their Immunoreceptor Tyrosine based Switch Motifs (ITSMs). Accumulating evidence suggest that the members of this family are intimately involved in different physiological and pathophysiological events such as regulation of immune responses and entry pathways of certain viruses. Recently, other functions of SLAM, principally in the pathophysiology of neoplastic transformations have also been deciphered. These new findings may prompt SLAM to be considered as new tumor markers, diagnostic tools or potential therapeutic targets for controlling the tumor progression. In this review, we summarize the major observations describing the implications and features of SLAM in oncology and discuss the therapeutic potential attributed to these molecules.
Insights
Signaling Lymphocytic Activation Molecules (SLAM) receptors, initially known for immune cell roles, are now implicated in cancer. Their functions in neoplastic transformations suggest potential as tumor markers and therapeutic targets.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Signaling Lymphocytic Activation Molecules (SLAM) family receptors are primarily known for their roles in immune cell function.
- These receptors utilize Immunoreceptor Tyrosine based Switch Motifs (ITSMs) to interact with SH2 domain-containing proteins, mediating signaling pathways.
- Emerging evidence highlights SLAM family involvement in diverse physiological and pathophysiological processes, including viral entry and immune response regulation.
Purpose of the Study:
- To review the significant findings on the implications and characteristics of SLAM receptors in oncology.
- To explore the recently deciphered roles of SLAM in the pathophysiology of neoplastic transformations.
- To discuss the potential of SLAM as novel tumor markers, diagnostic tools, or therapeutic targets for cancer progression.
Main Methods:
- Literature review summarizing major observations on SLAM family receptors in cancer.
- Analysis of evidence linking SLAM functions to neoplastic transformations.
- Discussion of therapeutic strategies targeting SLAM in oncological contexts.
Main Results:
- SLAM family receptors, beyond their immune functions, are increasingly recognized for their involvement in cancer development and progression.
- Specific roles of SLAM in neoplastic transformations have been elucidated, highlighting their potential significance.
- The study identifies SLAM as promising candidates for new tumor markers, diagnostic applications, and therapeutic interventions in oncology.
Conclusions:
- SLAM family receptors represent a critical link between immune regulation and cancer pathophysiology.
- Their involvement in neoplastic transformations positions them as valuable targets for cancer research and treatment.
- Further investigation into SLAM's oncological roles could lead to innovative diagnostic and therapeutic strategies.
Related Concept Videos
Types of Signaling Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Yeast Signaling
What is Cell Signaling?
Intracellular Signaling Cascades
Bacterial Signaling

